Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01209923 · ClinicalTrials.gov registry record · NA

Validation of the Stayhealthy BC1 Body Comp Analyzer

A NA study of Body Composition, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
362
Enrollment target
1
Study location

NCT01209923: Completed NA study of Body Composition, sponsored by University of Southern California.

NCT01209923 is a NA study of Body Composition that has completed, run by University of Southern California. The registered enrollment target is 362 participants, above the 98-participant average among 20 other Body Composition trials with a reported enrollment target (269% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01209923, a NA study of Body Composition, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
362 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to validate the Stayhealthy BC1 bioelectrical impedance analyzer to assess percent body fat in children and adults. The BC1 was compared to dual-energy x-ray absorptiometry assessment of body fat for adults and to hydrostatic weighing assessment of body fat for children. We hypothesized that the BC1 would provide similar measures of body fat between devices with acceptable limits of agreement.

Primary Outcome

Percent body was compared between devices

Conditions Studied

Interventions

  • DEVICE BC1

Study Locations (1)

California

  • USC Clinical Exercise Research Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 362 participants
Start Date 2007-05
Est. Completion 2009-08
Phase NA
University of Southern California

617 total trials

What the finished NCT01209923 record still lists

NCT01209923 is an interventional study that assigns participants to a tested intervention. The registered 362 participants enrollment target is mid-sized for trials with a published cap, above the 98-participant average among 20 other Body Composition trials with a reported enrollment target (269% higher).

The record links to 1 condition, with Body Composition appearing as the primary indexed condition, and to 1 intervention - of which BC1 is the first listed.

NCT01209923 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01209923 about?

NCT01209923 is a clinical study titled "Validation of the Stayhealthy BC1 Body Comp Analyzer". The purpose of this study was to validate the Stayhealthy BC1 bioelectrical impedance analyzer to assess percent body fat in children and adults. The BC1 was compared to dual-energy x-ray absorptiometry assessment of body fat for adults and to hydrostatic weighing assessment of body fat for children...

What is the current status of trial NCT01209923?

This trial is currently completed. It is a NA study. The enrollment target is 362 participants. The study started on 2007-05. Estimated completion is 2009-08.

What conditions does trial NCT01209923 study?

This clinical trial studies the following conditions: Body Composition.

What interventions are being tested in trial NCT01209923?

The interventions under investigation include: BC1 (DEVICE).

Who is sponsoring clinical trial NCT01209923?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01209923 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Composition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01209923's enrollment target sits among peer trials

362 3rd of 20 higher than 18 of 20 other Body Composition trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Body Composition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04988555 · 362 participants · Phase 1

    A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation

  • NCT05536141 · 362 participants · Phase 1

    A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

  • NCT06534983 · 362 participants · Phase 2

    A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)

  • NCT06472245 · 363 participants · Phase 3

    Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01209923, the US trial registry maintained by the National Library of Medicine. NCT01209923 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.